Infection Prevention

Aug. 25, 2023

Industry leaders address challenges that remain

California Confirms First Known Case of Clade I Mpox

Nov. 18, 2024

10.3 Million People Infected by Measles in 2023

Nov. 15, 2024

Canadian Teenager in Critical Condition Confirmed to Have H5N1

Nov. 14, 2024

Research Suggests Taking Antibiotics During Influenza Infection Increases Risk of Developing Bacterial Pneumonia

Nov. 13, 2024

New Studies Indicate Paxlovid Reduces Hospitalizations and Death

Nov. 12, 2024

Infection Prevention

Flu Activity Remains Low Nationally, Says CDC

Nov. 11, 2024

Study Finds 7% of Farm Workers Exposed to H5N1-Infected Cattle Were Infected

Nov. 8, 2024

Study Suggests Long COVID Is Less Likely to Occur in Those Who Have Recently Been Vaccinated

Nov. 7, 2024

Emory Launches Healthcare Test Kitchen Lab to Research HAIs

Nov. 6, 2024

Avian Flu Detected in Pigs for the First Time in U.S.

Oct. 31, 2024

H5N1 Virus Isolated from Infected Farm Worker Lethal in Mice and Ferrets

Oct. 29, 2024

Respiratory Roundup

Oct. 29, 2024

CDC Recommends Lowering Age for Pneumococcal Vaccination to 50 Years Old

Oct. 25, 2024

Previously, the recommendation was for adults 65 and older to receive the vaccine.

USDA and HHS Detail New Actions to Halt Spread of Bird Flu

Oct. 25, 2024

USDA, CDC, and HHS are expending manpower and money to assist with the H5N1 outbreaks, especially in California and Washington.

ISMP Report on Vaccine Errors

Oct. 25, 2024

25% of errors are attributed to the wrong vaccine being administered.

Pfizer's ABRYSVO RSV Vaccine Granted FDA Approval for At-Risk Adults

Oct. 24, 2024

Pfizer's ABRYSVO RSV vaccine, approved by the FDA, offers broad protection for adults at risk of RSV, including pregnant individuals, based on inferred efficacy from a pivotal...

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine Six Months After First Dose